Development of Electrochemical Biosensor for miR204-Based Cancer Diagnosis

Interdiscip Sci. 2022 Jun;14(2):596-606. doi: 10.1007/s12539-022-00508-0. Epub 2022 Apr 26.

Abstract

With increase in cancer burden worldwide and poor survival rates due to delayed diagnosis, it is pertinent to develop a device for early diagnosis. We report an electrochemical biosensor for quantification of miRNA-204 (miR-204) biomarker that is dysregulated in most of the cancers. The proposed methodology uses the gold nanoparticles-modified carbon screen-printed electrode for immobilization of single-stranded DNA probe against miR-204. Colloidal gold nanoparticles were synthesized using L-glutamic acid as reducing agent. Nanoparticles were characterized by UV-visible spectroscopy and transmission electron microscopy. Spherical gold nanoparticles were of 7-28 nm in size. Biosensor fabricated using these nanoparticles was characterized by cyclic voltammetry after spiking 0.1 fg/mL-0.1 µg/mL of miR-204 in fetal bovine serum. Response characteristics of the miR-204 biosensor displayed high sensitivity of 8.86 µA/µg/µL/cm2 with wide detection range of 15.5 aM to 15.5 nM. The low detection limit makes it suitable for early diagnosis and screening of cancer.

Keywords: Biosensors; Cancer detection; Early cancer diagnosis; Electrochemical detection; miR-204.

MeSH terms

  • Biosensing Techniques* / methods
  • Electrochemical Techniques
  • Gold
  • Humans
  • Metal Nanoparticles* / chemistry
  • MicroRNAs*
  • Neoplasms* / diagnosis

Substances

  • MIRN204 microRNA, human
  • MicroRNAs
  • Gold